Free Trial

MarketBeat Instant News Alerts

Aurora Cannabis logo with Medical background

Aurora Cannabis (NASDAQ:ACB) Posts Earnings Results, Misses Expectations By $0.04 EPS

MarketBeat

Aurora Cannabis (NASDAQ:ACB - Get Free Report) issued its earnings results on Wednesday. The company reported $0.07 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.11 by ($0.04). Aurora Cannabis had a net margin of 0.42% and a return on equity of 0.59%.

NASDAQ:ACB
Read Aurora Cannabis (NASDAQ:ACB) Posts Earnings Results, Misses Expectations By $0.04 EPS
Korn/Ferry International logo with Business Services background

Korn/Ferry International (NYSE:KFY) Issues Quarterly Earnings Results, Beats Estimates By $0.06 EPS

MarketBeat

Korn/Ferry International (NYSE:KFY - Get Free Report) announced its quarterly earnings results on Wednesday. The business services provider reported $1.32 earnings per share for the quarter, beating the consensus estimate of $1.26 by $0.06. Korn/Ferry International had a return on equity of 14.52% and a net margin of 9.01%.

NYSE:KFY
Read Korn/Ferry International (NYSE:KFY) Issues Quarterly Earnings Results, Beats Estimates By $0.06 EPS
GMS logo with Retail/Wholesale background

GMS (NYSE:GMS) Posts Earnings Results, Beats Expectations By $0.14 EPS

MarketBeat

GMS (NYSE:GMS - Get Free Report) issued its earnings results on Wednesday. The company reported $1.29 EPS for the quarter, beating the consensus estimate of $1.15 by $0.14. GMS had a net margin of 2.61% and a return on equity of 18.77%. The company had revenue of $1.33 billion for the quarter, compared to the consensus estimate of $1.30 billion. During the same quarter in the previous year, the company earned $1.93 EPS.

NYSE:GMS
Read GMS (NYSE:GMS) Posts Earnings Results, Beats Expectations By $0.14 EPS
Darden Restaurants logo with Retail/Wholesale background

Oppenheimer Forecasts Strong Price Appreciation for Darden Restaurants (NYSE:DRI) Stock

MarketBeat

Oppenheimer upped their price objective on Darden Restaurants from $230.00 to $250.00 and gave the stock an "outperform" rating in a research note on Wednesday.

NYSE:DRI
Read Oppenheimer Forecasts Strong Price Appreciation for Darden Restaurants (NYSE:DRI) Stock
Zoetis logo with Medical background

Zoetis (NYSE:ZTS) Downgraded to "Hold" Rating by Stifel Nicolaus

MarketBeat

Stifel Nicolaus downgraded Zoetis from a "buy" rating to a "hold" rating and set a $160.00 target price for the company. in a report on Wednesday.

NYSE:ZTS
Read Zoetis (NYSE:ZTS) Downgraded to "Hold" Rating by Stifel Nicolaus
Western Copper & Gold logo with Basic Materials background

Western Copper & Gold (NYSE:WRN) Given New $4.00 Price Target at HC Wainwright

MarketBeat

HC Wainwright lowered their price target on Western Copper & Gold from $4.25 to $4.00 and set a "buy" rating on the stock in a report on Wednesday.

NYSE:WRN
Read Western Copper & Gold (NYSE:WRN) Given New $4.00 Price Target at HC Wainwright

Trending News

All MarketBeat Instant News Alerts

UBS Group logo with Finance background

UBS Group (NYSE:UBS) Lowered to Underweight Rating by Morgan Stanley

MarketBeat
NYSE:UBS
Read UBS Group (NYSE:UBS) Lowered to Underweight Rating by Morgan Stanley
Stoneridge logo with Computer and Technology background

Stoneridge's (SRI) "Outperform" Rating Reiterated at Barrington Research

MarketBeat
NYSE:SRI
Read Stoneridge's (SRI) "Outperform" Rating Reiterated at Barrington Research
Ralph Lauren logo with Consumer Discretionary background

Ralph Lauren's (RL) Outperform Rating Reiterated at Telsey Advisory Group

MarketBeat
NYSE:RL
Read Ralph Lauren's (RL) Outperform Rating Reiterated at Telsey Advisory Group
REV Group logo with Transportation background

REV Group (NYSE:REVG) Upgraded by Morgan Stanley to Equal Weight Rating

MarketBeat
NYSE:REVG
Read REV Group (NYSE:REVG) Upgraded by Morgan Stanley to Equal Weight Rating
Q2 logo with Computer and Technology background

Q2 (NYSE:QTWO) Now Covered by Analysts at JPMorgan Chase & Co.

MarketBeat
NYSE:QTWO
Read Q2 (NYSE:QTWO) Now Covered by Analysts at JPMorgan Chase & Co.
NIKE logo with Consumer Discretionary background

NIKE (NYSE:NKE) Price Target Lowered to $66.00 at Needham & Company LLC

MarketBeat
NYSE:NKE
Read NIKE (NYSE:NKE) Price Target Lowered to $66.00 at Needham & Company LLC
Loma Negra Compania Industrial Argentina logo with Construction background

Loma Negra Compania Industrial Argentina (NYSE:LOMA) Now Covered by Citigroup

MarketBeat
NYSE:LOMA
Read Loma Negra Compania Industrial Argentina (NYSE:LOMA) Now Covered by Citigroup
Genworth Financial logo with Finance background

Genworth Financial (NYSE:GNW) Upgraded to Outperform at Keefe, Bruyette & Woods

MarketBeat
NYSE:GNW
Read Genworth Financial (NYSE:GNW) Upgraded to Outperform at Keefe, Bruyette & Woods
Smart Share Global logo with Consumer Discretionary background

Smart Share Global (NYSE:EM) Given Neutral Rating at Citigroup

MarketBeat
NYSE:EM
Read Smart Share Global (NYSE:EM) Given Neutral Rating at Citigroup
Chipotle Mexican Grill logo with Retail/Wholesale background

TD Securities Reaffirms Buy Rating for Chipotle Mexican Grill (NYSE:CMG)

MarketBeat
NYSE:CMG
Read TD Securities Reaffirms Buy Rating for Chipotle Mexican Grill (NYSE:CMG)
Verve Therapeutics logo with Medical background

Verve Therapeutics (NASDAQ:VERV) Receives Neutral Rating from HC Wainwright

MarketBeat
NASDAQ:VERV
Read Verve Therapeutics (NASDAQ:VERV) Receives Neutral Rating from HC Wainwright
Verve Therapeutics logo with Medical background

Lifesci Capital Reaffirms "Market Perform" Rating for Verve Therapeutics (NASDAQ:VERV)

MarketBeat
NASDAQ:VERV
Read Lifesci Capital Reaffirms "Market Perform" Rating for Verve Therapeutics (NASDAQ:VERV)
Verve Therapeutics logo with Medical background

Verve Therapeutics' (VERV) "Hold" Rating Reiterated at Jefferies Financial Group

MarketBeat
NASDAQ:VERV
Read Verve Therapeutics' (VERV) "Hold" Rating Reiterated at Jefferies Financial Group
Sarepta Therapeutics logo with Medical background

Sarepta Therapeutics (NASDAQ:SRPT) Downgraded to "Hold" Rating by TD Cowen

MarketBeat
NASDAQ:SRPT
Read Sarepta Therapeutics (NASDAQ:SRPT) Downgraded to "Hold" Rating by TD Cowen
Roivant Sciences logo with Medical background

HC Wainwright Reiterates Buy Rating for Roivant Sciences (NASDAQ:ROIV)

MarketBeat
NASDAQ:ROIV
Read HC Wainwright Reiterates Buy Rating for Roivant Sciences (NASDAQ:ROIV)
Nice logo with Computer and Technology background

Rosenblatt Securities Reaffirms Buy Rating for Nice (NASDAQ:NICE)

MarketBeat
NASDAQ:NICE
Read Rosenblatt Securities Reaffirms Buy Rating for Nice (NASDAQ:NICE)
nCino logo with Computer and Technology background

nCino (NASDAQ:NCNO) Coverage Initiated at JPMorgan Chase & Co.

MarketBeat
NASDAQ:NCNO
Read nCino (NASDAQ:NCNO) Coverage Initiated at JPMorgan Chase & Co.
Marvell Technology logo with Computer and Technology background

Rosenblatt Securities Reaffirms "Buy" Rating for Marvell Technology (NASDAQ:MRVL)

MarketBeat
NASDAQ:MRVL
Read Rosenblatt Securities Reaffirms "Buy" Rating for Marvell Technology (NASDAQ:MRVL)
Marvell Technology logo with Computer and Technology background

Marvell Technology's (MRVL) "Buy" Rating Reaffirmed at Needham & Company LLC

MarketBeat
NASDAQ:MRVL
Read Marvell Technology's (MRVL) "Buy" Rating Reaffirmed at Needham & Company LLC
Marvell Technology logo with Computer and Technology background

Benchmark Reiterates "Buy" Rating for Marvell Technology (NASDAQ:MRVL)

MarketBeat
NASDAQ:MRVL
Read Benchmark Reiterates "Buy" Rating for Marvell Technology (NASDAQ:MRVL)
Innoviz Technologies logo with Auto/Tires/Trucks background

Innoviz Technologies (NASDAQ:INVZ) Given New $2.53 Price Target at Westpark Capital

MarketBeat
NASDAQ:INVZ
Read Innoviz Technologies (NASDAQ:INVZ) Given New $2.53 Price Target at Westpark Capital
Immuneering logo with Medical background

Chardan Capital Reiterates Buy Rating for Immuneering (NASDAQ:IMRX)

MarketBeat
NASDAQ:IMRX
Read Chardan Capital Reiterates Buy Rating for Immuneering (NASDAQ:IMRX)
Immuneering logo with Medical background

Immuneering (NASDAQ:IMRX) Earns "Buy" Rating from Needham & Company LLC

MarketBeat
NASDAQ:IMRX
Read Immuneering (NASDAQ:IMRX) Earns "Buy" Rating from Needham & Company LLC
Eledon Pharmaceuticals logo with Medical background

Eledon Pharmaceuticals' (ELDN) "Buy" Rating Reaffirmed at HC Wainwright

MarketBeat
NASDAQ:ELDN
Read Eledon Pharmaceuticals' (ELDN) "Buy" Rating Reaffirmed at HC Wainwright

Featured Articles and Offers

Sector News